© 2004 by Oxford University Press
© 2004 Oxford University Press
ARTICLE |
Estrogen Signaling in Livers of Male Mice With Hepatocellular Carcinoma Induced by Exposure to Arsenic In Utero
Affiliations of authors: Inorganic Carcinogenesis Section, Laboratory of Comparative Carcinogenesis, National Cancer Institute at National Institute of Environmental Health Sciences, Research Triangle Park, NC (MPW, JL, HC, YX, WEA); Southwest Prefecture Endemic Prevention Station, Guizhou, China (YZ); Guiyang Medical College, Guizhou (MC); Basic Research Program, SAIC Frederick, National Cancer Institute-Frederick Cancer Research and Development Center, Frederick, MD (BAD)
Correspondence to: Michael P. Waalkes, PhD, Inorganic Carcinogenesis Section, Laboratory of Comparative Carcinogenesis, National Cancer Institute at National Institute of Environmental Health Sciences, MD F0–09, 111 Alexander Dr., Research Triangle Park, NC 27709 (e-mail: waalkes{at}niehs.nih.gov)
Background: Exposure of pregnant mice to inorganic arsenic induces a spectrum of tumors, including hepatocellular carcinoma (HCC), in their adult offspring similar to that induced by exposing adult mice to estrogenic compounds. To investigate whether arsenic exposure in utero causes altered estrogen signaling, we examined expression of estrogen receptor-
(ER-), cyclin D1 (an estrogen-responsive hepatic oncogene), and several cytochrome P450 genes (with sexually dimorphic liver expression patterns) in livers from adult male mice with in utero arsenic–induced HCC. Methods: Quantitative real-time reverse transcription–polymerase chain reaction was used to evaluate gene expression in livers of adult male mice that had (i.e., exposed mice; n = 8) or had not (i.e., control mice; n = 5) been exposed to arsenic in utero. DNA methylation status of portions of the ER- and cyclin D1 gene promoters in liver tissue was measured using methylation-specific polymerase chain reaction. Statistical tests were two-sided. Results: ER- mRNA levels were 3.1-fold (95% confidence interval [CI] = 2.0-fold to 4.3-fold) higher in livers of exposed mice than in those of control mice, and cyclin D1 levels were 3.0-fold (95% CI = 1.7-fold to 4.3-fold) higher. Exposed mice showed a feminized expression pattern of several cytochrome P450 genes, expressing the female-dominant CYP2A4 (P = .017 versus control) and CYP2B9 (P<.001) genes at 8.7 and 10.5 times, respectively, the level in control mice and expressing the male-dominant CYP7B1 at approximately one-fourth the level in control mice(P = .0012). Exposed mice exhibited reduced (by approximately 90%) methylation of the ER- gene promoter in liver DNA as compared with control mice; the cyclin D1 gene promoter was not methylated in either exposed or control mice. Conclusion: Altered estrogen signaling may play a role in induction of HCC by arsenic exposure in utero. Specifically, overexpression of ER-, potentially through promoter region hypomethylation, in livers of such mice may be linked to the hepatocarcinogenicity of arsenic.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J. C. States, S. Srivastava, Y. Chen, and A. Barchowsky Arsenic and Cardiovascular Disease Toxicol. Sci., February 1, 2009; 107(2): 312 - 323. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Liu and M. P. Waalkes Liver is a Target of Arsenic Carcinogenesis Toxicol. Sci., September 1, 2008; 105(1): 24 - 32. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-F. Coppin, W. Qu, and M. P. Waalkes Interplay between Cellular Methyl Metabolism and Adaptive Efflux during Oncogenic Transformation from Chronic Arsenic Exposure in Human Cells J. Biol. Chem., July 11, 2008; 283(28): 19342 - 19350. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Rahman, M. Vahter, E.-C. Ekstrom, M. Rahman, A. H. M. Golam Mustafa, M. A. Wahed, M. Yunus, and L.-A. Persson Association of Arsenic Exposure during Pregnancy with Fetal Loss and Infant Death: A Cohort Study in Bangladesh Am. J. Epidemiol., June 15, 2007; 165(12): 1389 - 1396. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Shen, J. Liu, Y. Xie, B. A. Diwan, and M. P. Waalkes Fetal Onset of Aberrant Gene Expression Relevant to Pulmonary Carcinogenesis in Lung Adenocarcinoma Development Induced by In Utero Arsenic Exposure Toxicol. Sci., February 1, 2007; 95(2): 313 - 320. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Ahsan, Y. Chen, F. Parvez, L. Zablotska, M. Argos, I. Hussain, H. Momotaj, D. Levy, Z. Cheng, V. Slavkovich, et al. Arsenic Exposure from Drinking Water and Risk of Premalignant Skin Lesions in Bangladesh: Baseline Results from the Health Effects of Arsenic Longitudinal Study Am. J. Epidemiol., June 15, 2006; 163(12): 1138 - 1148. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. P. Waalkes, J. Liu, J. M. Ward, D. A. Powell, and B. A. Diwan Urogenital Carcinogenesis in Female CD1 Mice Induced by In utero Arsenic Exposure Is Exacerbated by Postnatal Diethylstilbestrol Treatment Cancer Res., February 1, 2006; 66(3): 1337 - 1345. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Kawagoe and G. C. Grosveld MN1-TEL myeloid oncoprotein expressed in multipotent progenitors perturbs both myeloid and lymphoid growth and causes T-lymphoid tumors in mice Blood, December 15, 2005; 106(13): 4278 - 4286. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Chen, S. Li, J. Liu, B. A. Diwan, J. C. Barrett, and M. P. Waalkes Chronic inorganic arsenic exposure induces hepatic global and individual gene hypomethylation: implications for arsenic hepatocarcinogenesis Carcinogenesis, September 1, 2004; 25(9): 1779 - 1786. [Abstract] [Full Text] [PDF]
|
|